These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 7384730

  • 21. [Epidemiological aspects of the encephalopathies resulting from oral administration of bismuth (author's transl)].
    Martin-Bouyer G, Foulon B, Guerbois H, Barin C.
    Therapie; 1980; 35(3):307-13. PubMed ID: 7423418
    [No Abstract] [Full Text] [Related]

  • 22. [Bismuth encephalopathy].
    Krüger G.
    Fortschr Neurol Psychiatr; 1984 Jan; 52(1):24-31. PubMed ID: 6698481
    [Abstract] [Full Text] [Related]

  • 23. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
    Molina JA, Calandre L, Bermejo F, Posadas F, Fernández-Ortega JD.
    Med Clin (Barc); 1989 Jun 03; 93(1):20-2. PubMed ID: 2770373
    [Abstract] [Full Text] [Related]

  • 24. [Bismuth encephalopathy. Presentation of a case].
    Fernández Barreiro A, Sicilia Guillén J, Castejón Vera P, Escribano Soriano JB, Bautista Prados JG, Díaz Ortuño A.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1983 Jun 03; 11(2):127-32. PubMed ID: 6880891
    [No Abstract] [Full Text] [Related]

  • 25. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology].
    Olive G.
    Therapie; 1980 Jun 03; 35(3):305-6. PubMed ID: 6775384
    [No Abstract] [Full Text] [Related]

  • 26. [A case of post-traumatic necrosis of the head of the humerus].
    Luppino D, Vicenzi G, Capelli A.
    Chir Organi Mov; 1981 Jun 03; 67(4):467-70. PubMed ID: 7349840
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Encephalopathy after oral ingestion of bismuth salt over a short time period (10 days)].
    Davous P, Bouche P, Derouesne C, Castaigne P.
    Nouv Presse Med; 1977 Oct 29; 6(36):3336. PubMed ID: 593865
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Bismuth osteoarthropathies. Concern with bone bismuth dosage].
    Gaucher A, Netter P, Faure G, Pourel J, Hutin MF, Burnel D.
    Rev Rhum Mal Osteoartic; 1980 Jan 29; 47(1):31-6. PubMed ID: 7384715
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy].
    Escourolle R, Bourdon R, Galli A, Galle P, Jaudon MC, Hauw JJ, Gray F.
    Rev Neurol (Paris); 1977 Mar 29; 133(3):153-63. PubMed ID: 918459
    [Abstract] [Full Text] [Related]

  • 39. [Letter: Myoclonic encephalopathy and bismuth salt poisoning].
    Cambier J, Mason M, Dairou R.
    Nouv Presse Med; 1974 Dec 21; 3(44):2662. PubMed ID: 4459861
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.